Micro Imaging Technology (MMTC) Stock Price
Micro Imaging Technology Price
Revenue at Micro Imaging Technology has contracted by 13.8% per year over the past 13 years to 18,000.00 USD. Micro Imaging Technology's net margin stands at -18,444.6%, down from -119.4% several years earlier.
Micro Imaging Technology stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Micro Imaging Technology business model & stock analysis
Frequently asked questions about Micro Imaging Technology
The main competitors of Micro Imaging Technology Inc in the market include companies such as Agilent Technologies Inc., Bio-Rad Laboratories Inc., Bruker Corporation, and Thermo Fisher Scientific Inc.
The business model of Micro Imaging Technology Inc focuses on developing and commercializing proprietary microbial identification technology. This innovative company aims to revolutionize the way microorganisms are identified by providing rapid and accurate detection solutions. Micro Imaging Technology Inc's advanced software algorithms and hardware systems enable the identification of various pathogens in food safety, pharmaceutical, and clinical industries. Through its cutting-edge technology, Micro Imaging Technology Inc offers cost-effective and time-efficient solutions for microbial identification, helping businesses and organizations maintain quality control standards and ensure public safety.
Micro Imaging Technology Inc is primarily active in the industries of biotechnology and medical technology.
Micro Imaging Technology Inc (MIT) is a cutting-edge company specializing in the development and commercialization of innovative microbial identification technologies. Founded in [year], MIT has made significant strides in revolutionizing the way microorganisms are identified. With a focus on accuracy, speed, and cost-effectiveness, MIT's proprietary platform provides rapid microbial detection solutions for various industries, including food safety, pharmaceuticals, and clinical diagnostics. Leveraging advanced imaging and artificial intelligence, MIT's technology offers a non-destructive method for analyzing microorganisms, enabling faster decision-making and improved management of potential risks. Through consistent dedication to research and development, MIT continues to position itself as a leader in the field of microbial identification.
Micro Imaging Technology Inc has achieved several significant milestones. The company successfully developed and commercialized its Rapid Microbial Identifier (RMID) system, a cutting-edge technology that enables rapid bacterial identification. This groundbreaking system has revolutionized microbial detection and provides accurate and reliable results in just hours, compared to traditional methods that can take days. Micro Imaging Technology Inc has also built strong partnerships and collaborations with leading organizations in the industry, positioning itself as a key player in the field of microbial identification. Through its continuous innovation and dedication, the company has solidified its position as a leader in the field of rapid bacterial identification.
Micro Imaging Technology Inc is primarily present in the United States.
Micro Imaging Technology Inc represents values of innovation, quality, and customer satisfaction. With a strong corporate philosophy focused on developing cutting-edge imaging technology, the company aims to revolutionize the imaging industry. Micro Imaging Technology Inc is committed to delivering exceptional products and services that meet the unique needs of its customers. By combining advanced imaging solutions with excellent customer support, the company strives to build lasting relationships and maintain a strong reputation in the industry.
Converted at the current exchange rate, the Micro Imaging Technology share trades at 0.00 EUR (0.00 USD).
Micro Imaging Technology Inc (MIT) is a Texas-based company specializing in the development of rapid bacterial identification technologies. The company not only specializes in the manufacturing, sale, and marketing of devices and products, but also provides services aimed at diagnosing, treating, and preventing diseases and infections. MIT's main product is the MIT 1000 System, which is based on patented technology and offers rapid and precise bacterial identification. It eliminates the need for time-consuming culture procedures to deliver results within several days, and it is also cost-effective compared to other conventional identification methods. The system consists of a chemical sensor technology that performs spectral analysis of bacterial spectrums by analyzing proteins and lipids. In conjunction with commercially available software, it identifies bacteria in minutes. In addition to the MIT 1000 System, the company also offers the service of rapid bacterial identification and characterization. Samples are collected from various areas such as food processing, water quality, and medical facilities and analyzed by MIT. A growing focus is on the sensitive identification of bacteria that can cause severe diseases and infections, such as MRSA, E. coli, and Clostridium difficile. The company also provides training and consultancy services to prospective customers for understanding the technology and the use of the system. This ensures that customers obtain the best results from the system and that bacterial identification is carried out correctly. MIT's business model is based on the manufacturing and marketing of devices as well as the provision of services aimed at rapid, accurate, and cost-effective bacterial identification. The company aims to promote innovation in medical technology and increase business success by further developing the technology and expanding the service portfolio. The company operates in close collaboration with customers, suppliers, and stakeholders involved to ensure successful business operations, sustainable growth, and high customer satisfaction. Overall, MIT is an emerging company with a clear focus on bacterial identification, aligned with customer requirements and industry needs. Innovation and strengthening customer relationships are at the core of the business model, aiming to position the company as a leading provider in this field.
The revenue cannot currently be calculated for Micro Imaging Technology.
The profit cannot currently be calculated for Micro Imaging Technology.
The P/E ratio cannot be calculated for Micro Imaging Technology at the moment.
The P/S cannot be calculated for Micro Imaging Technology currently.
The Eulerpool Quality Score for Micro Imaging Technology is 4/10.
The ISIN of Micro Imaging Technology is US59484E2090. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Micro Imaging Technology is A1W06B. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Micro Imaging Technology is MMTC. The ticker symbol is used to trade Micro Imaging Technology shares on the stock exchange.
Micro Imaging Technology stock
Micro Imaging Technology Peer Group
Micro Imaging Technology Ticker
Micro Imaging Technology FIGI
All fundamentals and in-depth analysis of Micro Imaging Technology
Our stock analysis for Micro Imaging Technology stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Micro Imaging Technology. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.